Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251 » Globe Newswire - TCN.VN

Resmed Acquires VirtuOx 1-05-2025, 20:00

Update on offer for subscription 6-03-2023, 16:50

Bahrain Oncology Centre Amongst the First in the World to Offer Ground-breaking Sickle Cell and Transfusion Dependent Thalassemia Gene Therapy 23-05-2024, 02:18

28-07-2025, 17:00

Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW251, a Novel Glypican 3-Targeted Topoisomerase 1 Inhibitor Antibody-Drug Conjugate

Notified -

Globe Newswire28-07-2025, 17:00

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.